Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro

Simple item page
dc.contributor.authorDimas, K.
dc.contributor.authorYerlikaya, Azmi
dc.contributor.buuauthorUlukaya, Engin
dc.contributor.buuauthorSarımahmut, Mehmet
dc.contributor.buuauthorCevatemre, Buse
dc.contributor.buuauthorArı, Ferda
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Fen Edebiyat Fakültesi/Biyoloji Bölümü.tr_TR
dc.contributor.orcid0000-0003-2647-5875tr_TR
dc.contributor.orcid0000-0002-6729-7908tr_TR
dc.contributor.orcid0000-0003-4875-5472tr_TR
dc.contributor.researcheridK-5792-2018tr_TR
dc.contributor.researcheridAAG-8288-2021tr_TR
dc.contributor.researcheridAAG-7012-2021tr_TR
dc.contributor.researcheridAHD-2050-2022tr_TR
dc.contributor.scopusid6602927353tr_TR
dc.contributor.scopusid44661687400tr_TR
dc.contributor.scopusid55693788600tr_TR
dc.contributor.scopusid24376085300tr_TR
dc.date.accessioned2024-03-05T07:58:58Z
dc.date.available2024-03-05T07:58:58Z
dc.date.issued2014-03-13
dc.identifier.citationUlukaya, E. vd. (2014). "Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro". Biomedicine and Pharmacotherapy, 68(4), 477-482.en_US
dc.identifier.doihttps://doi.org/10.1016/j.biopha.2014.03.013en_US
dc.identifier.eissn1950-6007
dc.identifier.endpage482tr_TR
dc.identifier.issn0753-3322
dc.identifier.issue4tr_TR
dc.identifier.pubmed24755119tr_TR
dc.identifier.scopus2-s2.0-84901590452tr_TR
dc.identifier.startpage477tr_TR
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0753332214000419en_US
dc.identifier.urihttps://hdl.handle.net/11452/40199en_US
dc.identifier.volume68tr_TR
dc.identifier.wos000336538400012tr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevier en_US
dc.relation.bapUAP(T)-2010/37
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.relation.journalBiomedicine and Pharmacotherapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast canceren_US
dc.subjectCytotoxicityen_US
dc.subjectChemotherapyen_US
dc.subjectFenretinideen_US
dc.subjectTRAILen_US
dc.subjectGrowth-inhibitionen_US
dc.subjectDeath receptorsen_US
dc.subjectCisplatinen_US
dc.subjectInductionen_US
dc.subjectIdentificationen_US
dc.subjectCombinationen_US
dc.subjectP53en_US
dc.subjectTargeten_US
dc.subjectMechanismen_US
dc.subjectTrialen_US
dc.subjectResearch & experimental medicineen_US
dc.subjectPharmacology & pharmacyen_US
dc.subject.emtreeAdenosine triphosphateen_US
dc.subject.emtreeCaspase 3en_US
dc.subject.emtreeFenretinideen_US
dc.subject.emtreeNicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferaseen_US
dc.subject.emtreeTumor necrosis factor related apoptosis inducing liganden_US
dc.subject.emtreeAntineoplastic agenten_US
dc.subject.emtreeDrug effectsen_US
dc.subject.emtreeFenretinideen_US
dc.subject.emtreeApoptosisen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBreast canceren_US
dc.subject.emtreeBreast metastasisen_US
dc.subject.emtreeCancer cell cultureen_US
dc.subject.emtreeCell deathen_US
dc.subject.emtreeCell structureen_US
dc.subject.emtreeCell viability assayen_US
dc.subject.emtreeCytotoxicityen_US
dc.subject.emtreeEnzyme linked immunosorbent assayen_US
dc.subject.emtreeFluorescence imagingen_US
dc.subject.emtreeFluorescence microscopyen_US
dc.subject.emtreeIn vitro studyen_US
dc.subject.emtreePolyacrylamide gel electrophoresisen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeWestern blottingen_US
dc.subject.emtreeApoptosisen_US
dc.subject.emtreeBreast neoplasmsen_US
dc.subject.emtreeDrug potentiationen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMetabolismen_US
dc.subject.emtreeMetastasisen_US
dc.subject.emtreePathologyen_US
dc.subject.emtreeTumor cell lineen_US
dc.subject.meshAntineoplastic combined chemotherapy protocolsen_US
dc.subject.meshApoptosisen_US
dc.subject.meshBlotting, westernen_US
dc.subject.meshBreast neoplasmsen_US
dc.subject.meshCaspase 3en_US
dc.subject.meshCell line, tumoren_US
dc.subject.meshDrug synergismen_US
dc.subject.meshEnzyme-linked immunosorbent assayen_US
dc.subject.meshFemaleen_US
dc.subject.meshFenretinideen_US
dc.subject.meshHumansen_US
dc.subject.meshMicroscopy, fluorescenceen_US
dc.subject.meshNeoplasm metastasisen_US
dc.subject.meshPoly(adp-ribose) polymerasesen_US
dc.subject.meshTnf-related apoptosis-inducing liganden_US
dc.subject.scopusFenretinide; Apoptosis; Neuroblastomaen_US
dc.subject.wosMedicine, research & experimentalen_US
dc.subject.wosPharmacology & pharmacyen_US
dc.titleAdditive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitroen_US
dc.typeArticleen_US
dc.wos.quartileQ3en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science